{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:53:01Z","timestamp":1791269581172,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The aim of this study is to evaluate the prognostic factors of overall survival (OS) after haematopoietic stem cell transplant (HSCT) in acute lymphoblastic leukaemia (ALL) patients using accelerated failure time (AFT), Cox proportional hazard (PH), and Cox time-varying coefficient models.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>206 patients were enrolled after HSCH in Shariati Hospital between 1993 and 2007. There was evidence of marked departures from the proportional hazards assumption with two prognostic factors, relapse and chronic graft-versus-host disease (cGVHD) (P &lt; .001). Performance among AFT and Cox's models was assessed using explained variation and goodness of fit methods. Discrimination among the exponential, Weibull, generalized gamma (GG), log-logistic, and lognormal distributions was done using maximum likelihood and Akaike information criteria.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The 5-year OS was 52% (95%CI: 47.3\u201356.7). Peak mortality hazard occurred at months 6\u20137 after HSCT followed by a decreasing trend. In univariate analysis, the data was better fitted by GG distribution than by other distributions. Univariate analysis using GG distribution showed a positive association between OS with acute graft-versus-host disease (aGVHD) (P = .021), no relapse (P &lt; .001), cGVHD (P &lt; .001), neutrophil recovery (P &lt; .001) and platelet recovery (P &lt; .001). Based on Cox PH models; however cGVHD and relapse were the predictive factors of OS (P &lt; .001). Multivariate analysis indicated that, OS is related to relapse (P &lt; .001) and platelet recovery (P = .037), where predictive power of Weibull AFT models was superior to Cox PH model and Cox with time-varying coefficient (R<jats:sup>2<\/jats:sup> = 0.46 for AFT, R<jats:sup>2<\/jats:sup> = .21 for Cox PH and R<jats:sup>2<\/jats:sup> = .34 for Cox time-varying coefficient). Cox-Snell residual shows Weibull AFT fitted to data better than other distributions in multivariate analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>We concluded that AFT distributions can be a useful tool for recognizing prognostic factors of OS in acute lymphoblastic leukemia patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1756-9966-27-74","type":"journal-article","created":{"date-parts":[[2008,12,30]],"date-time":"2008-12-30T07:50:38Z","timestamp":1230623438000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Prognostic factors of survival time after hematopoietic stem cell transplant in acute lymphoblastic leukemia patients: Cox proportional hazard versus accelerated failure time models"],"prefix":"10.1186","volume":"27","author":[{"given":"Kourosh","family":"Sayehmiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad R","family":"Eshraghian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazem","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Alimoghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas Rahimi","family":"Foroushani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hojjat","family":"Zeraati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banafsheh","family":"Golestan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ardeshir","family":"Ghavamzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,11,23]]},"reference":[{"key":"73_CR1","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1600-0609.2006.00753.x","volume":"77","author":"QH Le","year":"2006","unstructured":"Le QH, Thomas X, Ecochard R, Iwaz J, Lheritier V, Michallet M, Fiere D: Initial and late prognostic factors to predict survival in adult acute lymphoblastic leukaemia 3. Eur J Haematol. 2006, 77: 471-479. 10.1111\/j.1600-0609.2006.00753.x.","journal-title":"Eur J Haematol"},{"key":"73_CR2","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1002\/pbc.21352","volume":"49","author":"LB Silverman","year":"2007","unstructured":"Silverman LB: Acute lymphoblastic leukemia in infancy. Pediatr Blood Cancer. 2007, 49: 1070-1073. 10.1002\/pbc.21352.","journal-title":"Pediatr Blood Cancer"},{"key":"73_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/sj.bmt.1701342","volume":"22","author":"AC Mertens","year":"1998","unstructured":"Mertens AC, Ramsay NK, Kouris S, Neglia JP: Patterns of gonadal dysfunction following bone marrow transplantation. Bone Marrow Transplant. 1998, 22: 345-350. 10.1038\/sj.bmt.1701342.","journal-title":"Bone Marrow Transplant"},{"key":"73_CR4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0360-3016(98)00441-6","volume":"43","author":"R Corvo","year":"1999","unstructured":"Corvo R, Paoli G, Barra S, Bacigalupo A, Van Lint MT, Franzone P, Frassoni F, Scarpati D, Bacigalupo A, Vitale V: Total body irradiation correlates with chronic graft versus host disease and affects prognosis of patients with acute lymphoblastic leukemia receiving an HLA identical allogeneic bone marrow transplant 10. Int J Radiat Oncol Biol Phys. 1999, 43: 497-503.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"73_CR5","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.bbmt.2008.02.018","volume":"14","author":"A Shigematsu","year":"2008","unstructured":"Shigematsu A, Kondo T, Yamamoto S, Sugita J, Onozawa M, Kahata K, Endo T, Shiratori S, Ota S, Obara M, et al: Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia 1. Biol Blood Marrow Transplant. 2008, 14: 568-575. 10.1016\/j.bbmt.2008.02.018.","journal-title":"Biol Blood Marrow Transplant"},{"key":"73_CR6","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/sj.bmt.1703951","volume":"31","author":"H Esperou","year":"2003","unstructured":"Esperou H, Boiron JM, Cayuela JM, Blanchet O, Kuentz M, Jouet JP, Milpied N, Cahn JY, Faucher C, Bourhis JH, et al: A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society 5. Bone Marrow Transplant. 2003, 31: 909-918. 10.1038\/sj.bmt.1703951.","journal-title":"Bone Marrow Transplant"},{"key":"73_CR7","first-page":"591","volume":"18","author":"A Zapatero","year":"1996","unstructured":"Zapatero A, d Martin V, Pinar B, Rodriguez F, Marin A, Cerezo L, Dominguez P, Perez TA: Prognostic factors affecting leukemia relapse after allogeneic BMT conditioned with cyclophosphamide and fractionated TBI. Bone Marrow Transplant. 1996, 18: 591-596.","journal-title":"Bone Marrow Transplant"},{"key":"73_CR8","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1200\/JCO.1995.13.2.352","volume":"13","author":"C Uderzo","year":"1995","unstructured":"Uderzo C, Valsecchi MG, Bacigalupo A, Meloni G, Messina C, Polchi P, Di GG, Dini G, Miniero R, Locatelli F, et al: Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy: ten-year experience of the Italian Bone Marrow Transplantation Group and the Italian Pediatric Hematology Oncology Association 2. J Clin Oncol. 1995, 13: 352-358.","journal-title":"J Clin Oncol"},{"key":"73_CR9","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S0140-6736(95)92710-7","volume":"346","author":"A Borgmann","year":"1995","unstructured":"Borgmann A, Schmid H, Hartmann R, Baumgarten E, Hermann K, Klingebiel T, Ebell W, Zintl F, Gadner H, Henze G: Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis. The Berlin-Frankfurt-Munster Study Group 1. Lancet. 1995, 346: 873-876. 10.1016\/S0140-6736(95)92710-7.","journal-title":"Lancet"},{"key":"73_CR10","doi-asserted-by":"crossref","unstructured":"Allogeneic bone marrow transplantation forleukaemia in Europe. Report from the Working Party on Leukaemia, European Group for Bone Marrow Transplantation 29. Lancet. 1988, 1: 1379-1382.","DOI":"10.1016\/S0140-6736(88)92190-3"},{"key":"73_CR11","first-page":"458","volume":"67","author":"C Jacquillat","year":"1980","unstructured":"Jacquillat C, Weil M, Auclerc MF, Schaison G, Chastang C, Harousseau JL, Bauters F, Olive D, Griscelli C, Bonnet M, et al: Application of the study of prognostic factors to the treatment of childhood (less than 20 years old) acute lymphoblastic leukemia 20. Bull Cancer. 1980, 67: 458-469.","journal-title":"Bull Cancer"},{"key":"73_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/hon.2900070409","volume":"7","author":"P Fenaux","year":"1989","unstructured":"Fenaux P, Lai JL, Morel P, Nelken B, Taboureau O, Deminatti M, Bauters F: Cytogenetics and their prognostic value in childhood and adult acute lymphoblastic leukemia (ALL) excluding L3. Hematol Oncol. 1989, 7: 307-317. 10.1002\/hon.2900070409.","journal-title":"Hematol Oncol"},{"key":"73_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/hon.2900130206","volume":"13","author":"IJ Neilly","year":"1995","unstructured":"Neilly IJ, Ogston M, Bennett B, Dawson AA: High grade non-Hodgkins lymphoma in the elderly \u2013 12 year experience in the Grampian Region of Scotland. Hematol Oncol. 1995, 13: 99-106. 10.1002\/hon.2900130206.","journal-title":"Hematol Oncol"},{"key":"73_CR14","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1002\/sim.1251","volume":"21","author":"J Orbe","year":"2002","unstructured":"Orbe J, Ferreira E, Nunez-Anton V: Comparing proportional hazards and accelerated failure time models for survival analysis. Stat Med. 2002, 21: 3493-3510. 10.1002\/sim.1251.","journal-title":"Stat Med"},{"key":"73_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1365-2753.2007.00806.x","volume":"14","author":"JL Moran","year":"2008","unstructured":"Moran JL, Bersten AD, Solomon PJ, Edibam C, Hunt T: Modelling survival in acute severe illness: Cox versus accelerated failure time models 1. J Eval Clin Pract. 2008, 14: 83-93.","journal-title":"J Eval Clin Pract"},{"key":"73_CR16","first-page":"61","volume-title":"survival Analysis using the SAS system a practical guide","author":"D Allison Paul","year":"1995","unstructured":"Allison Paul D: survival Analysis using the SAS system a practical guide. 1995, SaS Institutes, 61-249."},{"key":"73_CR17","doi-asserted-by":"crossref","DOI":"10.1007\/0-387-29150-4","volume-title":"Survival Analysis \u2013 A Self-Learning Text","author":"DG Kleinbaum","year":"2005","unstructured":"Kleinbaum DG, Klein M: Survival Analysis \u2013 A Self-Learning Text. 2005, Springer-Verlag"},{"key":"73_CR18","first-page":"83","volume-title":"Survival analysis techniques for censored and truncated data","author":"PMM Klien John","year":"1997","unstructured":"Klien John PMM: Survival analysis techniques for censored and truncated data. 1997, Springer-Verlag, 83-400."},{"key":"73_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/978-1-4899-3115-3","volume-title":"Modeling survival data in medical research","author":"D Collett","year":"1994","unstructured":"Collett D: Modeling survival data in medical research. 1994, Landon: Chapman & Hall, 150-237."},{"key":"73_CR20","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.2165\/00003088-200544120-00010","volume":"44","author":"F Saint-Marcoux","year":"2005","unstructured":"Saint-Marcoux F, Knoop C, Debord J, Thiry P, Rousseau A, Estenne M, Marquet P: Pharmacokinetic study of tacrolimus in cystic fibrosis and non-cystic fibrosis lung transplant patients and design of Bayesian estimators using limited sampling strategies 14. Clin Pharmacokinet. 2005, 44: 1317-1328. 10.2165\/00003088-200544120-00010.","journal-title":"Clin Pharmacokinet"},{"key":"73_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED: Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974, 18: 295-304. 10.1097\/00007890-197410000-00001.","journal-title":"Transplantation"},{"key":"73_CR22","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","volume":"11","author":"AH Filipovich","year":"2005","unstructured":"Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, Martin P, Chien J, Przepiorka D, Couriel D, et al: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report 1. Biol Blood Marrow Transplant. 2005, 11: 945-956. 10.1016\/j.bbmt.2005.09.004.","journal-title":"Biol Blood Marrow Transplant"},{"key":"73_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/10428190210204","volume":"43","author":"Y Nannya","year":"2002","unstructured":"Nannya Y, Kanda Y, Oshima K, Kaneko M, Yamamoto R, Chizuka A, Hamaki T, Suguro M, Matsuyama T, Takezako N, et al: Prognostic factors in elderly patients with acute myelogenous leukemia: a single center study in Japan. Leuk Lymphoma. 2002, 43: 83-87. 10.1080\/10428190210204.","journal-title":"Leuk Lymphoma"},{"key":"73_CR24","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/j.1365-2141.1993.tb03170.x","volume":"85","author":"PR Johnson","year":"1993","unstructured":"Johnson PR, Hunt LP, Yin JA: Prognostic factors in elderly patients with acute myeloid leukaemia: development of a model to predict survival. Br J Haematol. 1993, 85: 300-306. 10.1111\/j.1365-2141.1993.tb03170.x.","journal-title":"Br J Haematol"},{"key":"73_CR25","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1001\/jama.1993.03510100083038","volume":"270","author":"WA Knaus","year":"1993","unstructured":"Knaus WA, Harrell FE, Fisher CJ, Wagner DP, Opal SM, Sadoff JC, Draper EA, Walawander CA, Conboy K, Grasela TH: The clinical evaluation of new drugs for sepsis. A prospective study design based on survival analysis. JAMA. 1993, 270: 1233-1241. 10.1001\/jama.270.10.1233.","journal-title":"JAMA"},{"key":"73_CR26","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/biomet\/77.1.147","volume":"77","author":"T Thernneau","year":"1990","unstructured":"Thernneau T, Grambsch P, Fleming T: Martingale-based residuals for survival models. Biometrika. 1990, 77: 657-671. 10.1093\/biomet\/77.1.147.","journal-title":"Biometrika"},{"key":"73_CR27","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/sim.4780090503","volume":"9","author":"EL Korn","year":"1990","unstructured":"Korn EL, Simon R: Measures of explained variation for survival data 3. Stat Med. 1990, 9: 487-503. 10.1002\/sim.4780090503.","journal-title":"Stat Med"},{"key":"73_CR28","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","volume":"81","author":"PM Grambsch","year":"1994","unstructured":"Grambsch PM, Therneau TM: Proportinal hazard test and diagnostics based on weighted residuals. Biometrika. 1994, 81: 515-526. 10.1093\/biomet\/81.3.515.","journal-title":"Biometrika"},{"key":"73_CR29","volume-title":"Stata Statistical Software:Release 8.0","author":"StataCorp","year":"2003","unstructured":"StataCorp: Stata Statistical Software:Release 8.0. 2003, College Station. TX:Stata Corporation"},{"key":"73_CR30","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/sj.bjc.6601120","volume":"89","author":"MJ Bradburn","year":"2003","unstructured":"Bradburn MJ, Clark TG, Love SB, Altman DG: Survival analysis Part III: multivariate data analysis \u2013 choosing a model and assessing its adequacy and fit 3. Br J Cancer. 2003, 89: 605-611. 10.1038\/sj.bjc.6601120.","journal-title":"Br J Cancer"},{"key":"73_CR31","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1182\/blood.V99.6.2265","volume":"99","author":"S Verstovsek","year":"2002","unstructured":"Verstovsek S, Kantarjian H, Manshouri T, Cortes J, Giles FJ, Rogers A, Albitar M: Prognostic significance of cellular vascular endothelial growth factor expression in chronic phase chronic myeloid leukemia. Blood. 2002, 99: 2265-2267. 10.1182\/blood.V99.6.2265.","journal-title":"Blood"},{"key":"73_CR32","first-page":"1180","volume":"30","author":"S Sakamoto","year":"1989","unstructured":"Sakamoto S, Kurata H, Miwa A: [Multivariate analysis of prognostic factors influencing survival in chronic myelogenous leukemia]. Rinsho Ketsueki. 1989, 30: 1180-1184.","journal-title":"Rinsho Ketsueki"},{"key":"73_CR33","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/sim.4780020223","volume":"2","author":"S Bennett","year":"1983","unstructured":"Bennett S: Analysis of survival data by the proportional odds model. Stat Med. 1983, 2: 273-277. 10.1002\/sim.4780020223.","journal-title":"Stat Med"},{"key":"73_CR34","volume-title":"Stat Methods Med Res","author":"LF Meira-Machado","year":"2008","unstructured":"Meira-Machado LF, Una-Alvarez JD, Cadarso-Suarez C, Andersen P: Multi-state models for the analysis of time-to-event data 2. Stat Methods Med Res. 2008"},{"key":"73_CR35","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1002\/sim.2712","volume":"26","author":"H Putter","year":"2007","unstructured":"Putter H, Fiocco M, Geskus RB: Tutorial in biostatistics: competing risks and multi-state models 6. Stat Med. 2007, 26: 2389-2430. 10.1002\/sim.2712.","journal-title":"Stat Med"},{"key":"73_CR36","doi-asserted-by":"publisher","first-page":"4352","DOI":"10.1002\/sim.2836","volume":"26","author":"C Cox","year":"2007","unstructured":"Cox C, Chu H, Schneider MF, Munoz A: Parametric survival analysis and taxonomy of hazard functions for the generalized gamma distribution. Stat Med. 2007, 26: 4352-4374. 10.1002\/sim.2836.","journal-title":"Stat Med"},{"key":"73_CR37","volume-title":"Hematopoietic Stem Cell Transplantation. eMedicine Specialties","author":"Kolb E Anders","year":"2006","unstructured":"Anders Kolb: Hematopoietic Stem Cell Transplantation. eMedicine Specialties. 2006, eMedicine Specialties"},{"key":"73_CR38","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1182\/blood-2001-11-0059","volume":"100","author":"M Zecca","year":"2002","unstructured":"Zecca M, Prete A, Rondelli R, Lanino E, Balduzzi A, Messina C, Fagioli F, Porta F, Favre C, Pession A, et al: Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome. Blood. 2002, 100: 1192-1200. 10.1182\/blood-2001-11-0059.","journal-title":"Blood"},{"key":"73_CR39","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S1083-8791(03)00149-6","volume":"9","author":"K Doney","year":"2003","unstructured":"Doney K, Hagglund H, Leisenring W, Chauncey T, Appelbaum FR, Storb R: Predictive factors for outcome of allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia. Biol Blood Marrow Transplant. 2003, 9: 472-481. 10.1016\/S1083-8791(03)00149-6.","journal-title":"Biol Blood Marrow Transplant"},{"key":"73_CR40","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.bbmt.2007.07.001","volume":"13","author":"M Jagasia","year":"2007","unstructured":"Jagasia M, Giglia J, Chinratanalab W, Dixon S, Chen H, Frangoul H, Engelhardt B, Goodman S, Greer J, Kassim A, et al: Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria. Biol Blood Marrow Transplant. 2007, 13: 1207-1215. 10.1016\/j.bbmt.2007.07.001.","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-9966-27-74.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T02:53:26Z","timestamp":1630464806000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/1756-9966-27-74"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,23]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["73"],"URL":"https:\/\/doi.org\/10.1186\/1756-9966-27-74","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,23]]},"assertion":[{"value":"30 August 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"74"}}